Regeneron Pharmaceuticals (REGN) Acquisitions (2023 - 2025)

Regeneron Pharmaceuticals' Acquisitions history runs 3 years deep, the most recent figure standing at $300000.0 for Q4 2025.

• On a quarterly basis, Acquisitions fell 97.39% year-over-year to $300000.0 in Q4 2025; TTM through Dec 2025 was $14.8 million, a 77.71% decrease from a year earlier, with the FY2025 full-year figure at $3.3 million, down 80.0% from the prior year.
• Acquisitions slipped to $300000.0 in Q4 2025 per REGN's latest filing, from $3.0 million in the prior quarter.
• Across five years, Acquisitions topped out at $51.1 million in Q3 2023 and bottomed at $300000.0 in Q4 2025.
• The 3-year median for Acquisitions is $3.8 million (2023), against an average of $13.9 million.
• Across the five-year window, Acquisitions jumped 202.63% in 2024 and plunged 97.39% in 2025, its largest moves.
• Year by year, Acquisitions stood at $3.8 million in 2023, then soared by 202.63% to $11.5 million in 2024, then plunged by 97.39% to $300000.0 in 2025.
• Per Business Quant, the three latest REGN Acquisitions figures stand at $300000.0 (Q4 2025), $3.0 million (Q3 2025), and $11.5 million (Q4 2024).